Von Willebrand factor promotes endothelial cell adhesion via an Arg-Gly-Asp-dependent mechanism.
Open Access
- 1 July 1989
- journal article
- research article
- Published by Rockefeller University Press in The Journal of cell biology
- Vol. 109 (1) , 367-375
- https://doi.org/10.1083/jcb.109.1.367
Abstract
Von Willebrand factor (vWF) is a constitutive and specific component of endothelial cell (EC) matrix. In this paper we show that, in vitro, vWF can induce EC adhesion and promote organization of microfilaments and adhesion plaques. In contrast, human vascular smooth muscle cells and MG63 osteosarcoma cells did not adhere and spread on vWF. Using antibodies to the beta chains of fibronectin (beta 1) and vitronectin (beta 3) receptors it was found that ECs adherent to vWF show clustering of both receptors. The beta 1 receptor antibodies are arranged along stress fibers at sites of extracellular matrix contact while the beta 3 receptor antibodies were sharply confined at adhesion plaques. ECs release and organize endogenous fibronectin early during adhesion to vWF. Upon blocking protein synthesis and secretion, ECs can equally adhere and spread on vWF but, while the beta 3 receptors are regularly organized, the beta 1 receptors remain diffuse. This suggests that the organization of the beta 1 receptors depend on the release of fibronectin and/or other matrix proteins operated by the same cell. Antibodies to the beta 3 receptors fully block EC adhesion to vWF and detach ECs seeded on this substratum. In contrast, antibodies to the beta 1 receptors are poorly active. Overall these results fit with an accessory role of beta 1 receptors and indicate a leading role for the beta 3 receptors in EC interaction with vWF. To identify the EC binding domain on vWF we used monoclonal antibodies produced against a peptide representing the residues Glu1737-Ser1750 of the mature vWF and thought to be important in mediating its binding to the platelet receptor glycoprotein IIb-IIIa. We found that the antibody that recognizes the residues 1,744-1,746, containing the Arg-Gly-Asp sequence, completely inhibit EC adhesion to vWF whereas a second antibody recognizing the adjacent residues 1,740-1,742 (Arg-Gly-Asp-free) is inactive. Both antibodies do not interfere with EC adhesion to vitronectin. This defines the molecular domain on vWF that is specifically recognized by ECs and reaffirms the direct role of the Arg-Gly-Asp sequence as the integrin receptor recognition site also in the vWF molecule.Keywords
This publication has 44 references indexed in Scilit:
- Proteolytic processing of presecretory proteins is required for development of biological activities in pancreatic exocrine proteins.Journal of Biological Chemistry, 1983
- The binding of fibrinogen to its platelet receptor.Journal of Biological Chemistry, 1982
- Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets.Journal of Clinical Investigation, 1982
- Evidence that Vascular Endothelial Cells Can Induce the Retraction of Fibrin ClotsExperimental Biology and Medicine, 1981
- Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent.Journal of Clinical Investigation, 1981
- Shear Rate Dependent Inhibition of Platelet Adhesion and Aggregation on Collagenous Surfaces by Antibodies to Human Factor VIII/von Willebrand FactorBritish Journal of Haematology, 1980
- Human blood platelet adhesion to artery subendothelium is mediated by factor VIII–Von Willebrand factor bound to the subendotheliumNature, 1979
- Monovalent ionophores inhibit secretion of procollagen and fibronectin from cultured human fibroblastsProceedings of the National Academy of Sciences, 1979
- Synthesis of Antihemophilic Factor Antigen by Cultured Human Endothelial CellsJournal of Clinical Investigation, 1973
- The purification of human fibrinogenBiochemical Journal, 1955